The compelling offer CYDY can and has to make to t
Post# of 148168
(Total Views: 795)
Posted On: 10/23/2020 12:38:26 AM
The compelling offer CYDY can and has to make to the sites is this: if you have severe or critical patients that worsen on your SOC treatments, you can ALWAYS enroll them into the trial to give them another chance, without harming them since it is perfectly safe and we take them all.. .
Good point lorbas. Are you also suggesting that if LL fails to be advanced by the FDA as a monotherapy we should consider the option of blending LL with Rem?
Would such a mix help to tame the side-effects associated with Rem? Is it possible that the blended mix (Rem + LL) might produce a more toxic effect than Rem's side-effect alone?
Cheers
Read More: https://investorshangout.com/post/view?id=593...z6bfIB9jGi
Good point lorbas. Are you also suggesting that if LL fails to be advanced by the FDA as a monotherapy we should consider the option of blending LL with Rem?
Would such a mix help to tame the side-effects associated with Rem? Is it possible that the blended mix (Rem + LL) might produce a more toxic effect than Rem's side-effect alone?
Cheers
Read More: https://investorshangout.com/post/view?id=593...z6bfIB9jGi
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼